Articles Tagged with Elan

Stephen A. Cohen and SAC Capital will pay a group of Elan Corp. investors $135M to settle their insider trading case against him and the firm. The plaintiffs had contended that sustained they financial losses because of insider trading that involved Elan shares. A judge still has to approve the settlement.

Ex-SAC Capital money manager Mathew Martoma was convicted two years ago for making $285M for SAC Capital on trades involving Elan and Wyeth, both pharmaceutical companies. He used insider information about the clinical trials of an Alzheimer’s drug that companies were developing together. Martoma is appealing his conviction while serving a 9-year prison sentence.

Although Cohen was not charged with insider trading, his firm pleaded guilty and consented to pay $1.8B in criminal and civil penalties. SAC Capital also changed its name to Point72 Asset Management LP. Cohen, meantime, went from managing other people’s money to only being allowed to oversee his multibillion-dollar fortune.

Continue Reading ›